Taurolidine is an antibacterial and antifungal agent with a mechanism of action that is less prone to development of antimicrobial resistance. A taurolidine/heparin lock solution carries a lower risk ...

A study published in Clinical Infectious Diseases examined the cost-effectiveness of antimicrobial locks for the prevention of central line-associated bloodstream infections. Antibiotic lock therapy ...

This is the first FDA-approved antimicrobial catheter lock solution. The FDA has approved taurolidine plus heparin (DefenCath®) catheter lock solution to reduce catheter-related bloodstream infections ...

Heparin labels updated to clarify drug strength Heparin label changes eliminate the need for clinicians to calculate the total amount of heparin medication in a product containing more than 1 mL.